Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Baxter

<< Previous

Bullboard Posts

Next >>

Comment by BlueJays9293on Dec 08, 2023 5:11pm

161 Views

Post# 35775708

RE:RE:RE:RE:RE:RE:RE:RE:Baxter

I completely agree. That would be a huge ethical dilema for the FDA because of the final 60 patients, 20 of them are going to be forced into the control group and have PMX withheld from them or in other words 5 people are going to die unnecessarily.

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features